News

Post-pandemic, working remotely is the norm for millions of displaced Americans who now work part- or full-time in their homes. Extended periods in front of screens has caused remote and desk job office workers alike to increasingly suffer symptoms of digital eye strain. Though no association exists between digital eye...

Among providers honored in medicine via recognition days, a highly representative group of teaching hospital physicians cannot be overlooked – residents and fellows. Led by the Gold Humanism Society, “Thank a Resident and Fellow Day” annually celebrates residents and fellows as vital contributors to patient care and healthcare workforce team...

UNC Department of Ophthalmology is pleased to welcome Assistant Professor of Ophthalmology Rodolfo Bonatti, MD, to our Glaucoma division! Dr. Bonatti has extensive academia and private practice experience and expertise in treating adult and pediatric glaucoma, as well as other areas, including cataract surgery and ocular trauma. He enjoys exploring...

Aging adults who face increased odds of developing a degenerative eye disease often narrow their eye health focus to watching for signs of the world’s two leading causes of blindness – cataract and glaucoma.  Lost in the messaging mix among seniors across the U.S. is adequate awareness of age-related macular...

UNC Department of Ophthalmology is pleased to welcome Professor of Ophthalmology Gabriella Szatmáry, MD, PhD, to our Neuro-Ophthalmology division!  Dr. Szatmary brings to our department and the institution a wealth of cross-disciplinary experience that includes direct teaching and conference presentations in Ophthalmology, Neurology, Neurosurgery, Neuroradiology and Neuro-Ophthalmology. She is widely...

Join UNC Department of Ophthalmology on Saturday, April 13th, 2024, for our annual UNC Eye Symposium at the William & Ida Friday Center for Continuing Education. This conference is designed for Ophthalmologists, Optometrists, Ophthalmic Technicians, and Photographers to hear the latest evidence-based diagnostic and medical/surgical approaches to comprehensive eye care...

An adult who faithfully visits his PCP for well-check exams shows no signs of mid-life worsening vision and falls short of scheduling a first-time comprehensive eye exam in his 40s. At age 50, he is diagnosed with glaucoma at an overdue screening, 10 years past the recommended age for first-time...

UNC Department of Ophthalmology would like to congratulate Han lab team member and UNC School of Medicine (SOM) second-year student (M2) Mary Kaufmann for winning Best Poster at two forums in mid-November, for posters overviewing several major laboratory studies led by Associate Professor Zongchao Han, PhD. At the Association of...

In December, even the most cautious of individuals can be affected by increased incidence of blunt force ocular trauma when year-end merry-making leads to careless behavior in adults and children alike. In a month loaded with gift-giving holidays and celebratory occasions, individuals are at risk of eye injuries in the...

Two UNC Department of Ophthalmology clinical faculty — Corneal Disease and Corneal Surgery specialist Hussam Banna, MD, and Oculofacial Plastic and Reconstructive Surgery specialist Daniel Rubinstein, MD — joined UNC Facial Nerve Center Director Matthew Miller, MD (Department of Otolaryngology) to perform the first corneal neurotization at UNC in October...

Approximately one-third of Americans with diabetes (Type 1, Type 2, or gestational) can develop diabetic retinopathy, a progression of the disease caused by high blood sugar levels damaging the back of the eye (retina). Diabetic retinopathy is the leading cause of blindness in working-age adults, and left undiagnosed and untreated, this...

* Over five+ years at UNC, Ophthalmology Assistant Professor of Research Hua Mei, PhD, has brought wet lab capacity a step closer to fostering translational treatment of corneal and anterior segment diseases. Her laboratory’s translational framework is leading the way in developing the first FDA-approved, anti-fibrotic drug therapy to treat...